
News
Biotechnology company Akero Therapeutics rose nearly 18% in pre-market trading on reports that Novo Nordisk AS will acquire the company

Biotechnology company Akero Therapeutics rose nearly 18% in pre-market trading on reports that Novo Nordisk AS will acquire the company